[Congressional Bills 104th Congress]
[From the U.S. Government Printing Office]
[S. 1897 Referred in House (RFH)]
2d Session
S. 1897
IN THE HOUSE OF REPRESENTATIVES
September 29, 1996
Referred to the Committee on Commerce
_______________________________________________________________________
AN ACT
To amend the Public Health Service Act to revise and extend certain
programs relating to the National Institutes of Health, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE; REFERENCES; AND TABLE OF CONTENTS
(a) Short Title.--This Act may be cited as the ``National
Institutes of Health Revitalization Act of 1996''.
(b) References.--Whenever in this Act an amendment is expressed in
terms of an amendment to a section or other provision, the reference
shall be considered to be made to a section or other provision of the
Public Health Service Act (42 U.S.C. 201 et seq.).
(c) Table of Contents.--The table of contents for this Act is as
follows:
Sec. 1. Short title; references; and table of contents
TITLE I--PROVISIONS RELATING TO THE NATIONAL INSTITUTES OF HEALTH
Sec. 101. Director's discretionary fund.
Sec. 102. Children's vaccine initiative.
TITLE II--PROVISIONS RELATING TO THE NATIONAL RESEARCH INSTITUTES
Sec. 201. Research on osteoporosis, paget's disease, and related bone
disorders.
Sec. 202. National Human Genome Research Institute.
Sec. 203. Increased amount of grant and other awards.
Sec. 204. Meetings of advisory committees and councils.
Sec. 205. Elimination or modification of reports.
TITLE III--SPECIFIC INSTITUTES AND CENTERS
Subtitle A--National Cancer Institute
Sec. 301. Authorization of appropriations.
Sec. 302. DES study.
Subtitle B--National Heart Lung and Blood Institute
Sec. 311. Authorization of appropriations.
Subtitle C--National Institute of Allergy and Infectious Diseases
Sec. 321. Terry Beirn community-based AIDS research initiative.
Subtitle D--National Institute of Child Health and Human Development
Sec. 331. Research centers for contraception and infertility.
Subtitle E--National Institute on Aging
Sec. 341. Authorization of appropriations.
Subtitle F--National Institute on Alcohol Abuse and Alcoholism
Sec. 351. Authorization of appropriations.
Sec. 352. National Alcohol Research Center.
Subtitle G--National Institute on Drug Abuse
Sec. 361. Authorization of appropriations.
Sec. 362. Medication development program.
Sec. 363. Drug Abuse Research Centers.
Subtitle H--National Institute of Mental Health
Sec. 371. Authorization of appropriations.
Subtitle I--National Center for Research Resources
Sec. 381. Authorization of appropriations.
Sec. 382. General Clinical Research Centers.
Sec. 383. Enhancement awards.
Sec. 384. Waiver of limitations.
Subtitle J--National Library of Medicine
Sec. 391. Authorization of appropriations.
Sec. 392. Increasing the cap on grant amounts.
TITLE IV--AWARDS AND TRAINING
Sec. 401. Medical scientist training program.
Sec. 402. Raise in maximum level of loan repayments.
Sec. 403. General loan repayment program.
Sec. 404. Clinical research assistance.
TITLE V--RESEARCH WITH RESPECT TO AIDS
Sec. 501. Comprehensive plan for expenditure of AIDS appropriations.
Sec. 502. Emergency AIDS discretionary fund.
TITLE VI--GENERAL PROVISIONS
Subtitle A--Authority of the Director of NIH
Sec. 601. Authority of the Director of NIH.
Subtitle B--Office of Rare Disease Research
Sec. 611. Establishment of Office for Rare Disease Research.
Subtitle C--Certain Reauthorizations
Sec. 621. National Research Service Awards.
Sec. 622. National Foundation for Biomedical Research.
Subtitle D--Miscellaneous Provisions
Sec. 631. Establishment of National Fund for Health Research.
Sec. 632. Definition of clinical research.
Sec. 633. Establishment of a pediatric research initiative.
Sec. 634. Diabetes research.
Sec. 635. Parkinson's research.
Sec. 636. Pain research consortium.
Subtitle E--Repeals and Conforming Amendments
Sec. 641. Repeals and conforming amendments.
TITLE I--PROVISIONS RELATING TO THE NATIONAL INSTITUTES OF HEALTH
SEC. 101. DIRECTOR'S DISCRETIONARY FUND.
Section 402(i)(3) (42 U.S.C. 282(i)(3)) is amended by striking
``$25,000,000'' and all that follows through the period and inserting
``such sums as may be necessary for fiscal year 1997.''.
SEC. 102. CHILDREN'S VACCINE INITIATIVE.
Section 404B(c) (42 U.S.C. 283d(c)) is amended by striking
``$20,000,000'' and all that follows through the period and inserting
``such sums as may be necessary for fiscal year 1997.''.
TITLE II--PROVISIONS RELATING TO THE NATIONAL RESEARCH INSTITUTES
SEC. 201. RESEARCH ON OSTEOPOROSIS, PAGET'S DISEASE, AND RELATED BONE
DISORDERS.
Section 409A(d) (42 U.S.C. 284e(d)) is amended by striking
``$40,000,000'' and all that follows through the period and inserting
``such sums as may be necessary for fiscal year 1997.''.
SEC. 202. NATIONAL HUMAN GENOME RESEARCH INSTITUTE.
(a) In General.--Part C of title IV (42 U.S.C. 285 et seq.) is
amended by adding at the end thereof the following new subpart:
``Subpart 18--National Human Genome Research Institute
``SEC. 464Z. PURPOSE OF THE INSTITUTE.
``(a) In General.--The general purpose of the National Human Genome
Research Institute is to characterize the structure and function of the
human genome, including the mapping and sequencing of individual genes.
Such purpose includes--
``(1) planning and coordinating the research goal of the
genome project;
``(2) reviewing and funding research proposals;
``(3) conducting and supporting research training;
``(4) coordinating international genome research;
``(5) communicating advances in genome science to the
public;
``(6) reviewing and funding proposals to address the
ethical, legal, and social issues associated with the genome
project (including legal issues regarding patents); and
``(7) planning and administering intramural, collaborative,
and field research to study human genetic disease.
``(b) Research.--The Director of the Institute may conduct and
support research training--
``(1) for which fellowship support is not provided under
section 487; and
``(2) that is not residency training of physicians or other
health professionals.
``(c) Ethical, Legal, and Social Issues.--
``(1) In general.--Except as provided in paragraph (2), of
the amounts appropriated to carry out subsection (a) for a
fiscal year, the Director of the Institute shall make available
not less than 5 percent of amounts made available for
extramural research for carrying out paragraph (6) of such
subsection.
``(2) Nonapplication.--With respect to providing funds
under subsection (a)(6) for proposals to address the ethical
issues associated with the genome project, paragraph (1) shall
not apply for a fiscal year if the Director of the Institute
certifies to the Committee on Commerce of the House of
Representatives, and to the Committee on Labor and Human
Resources of the Senate, that the Director has determined that
an insufficient number of such proposals meet the applicable
requirements of sections 491 and 492.
``(d) Transfer.--
``(1) In general.--There are transferred to the National
Human Genome Research Institute all functions which the
National Center for Human Genome Research exercised before the
date of enactment of this subpart, including all related
functions of any officer or employee of the National Center for
Human Genome Research. The personnel employed in connection
with, and the assets, liabilities, contracts, property,
records, and unexpended balances of appropriations,
authorizations, allocations, and other funds employed, used,
held, arising from, available to, or to be made available in
connection with the functions transferred under this subsection
shall be transferred to the National Human Genome Research
Institute.
``(2) Legal documents.--All orders, determinations, rules,
regulations, permits, agreements, grants, contracts,
certificates, licenses, regulations, privileges, and other
administrative actions which have been issued, made, granted,
or allowed to become effective in the performance of functions
which are transferred under this subsection shall continue in
effect according to their terms until modified, terminated,
superseded, set aside, or revoked in accordance with law.
``(3) References.--References in any other Federal law,
Executive order, rule, regulation, or delegation of authority,
or any document of or relating to the National Center for Human
Genome Research shall be deemed to refer to the National Human
Genome Research Institute.
``(e) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section, such sums as may be necessary
for fiscal year 1997.''.
(b) Conforming Amendments.--
(1) Section 401(b) (42 U.S.C. 281(b)) is amended--
(A) in paragraph (1), by adding at the end thereof
the following new subparagraph:
``(R) The National Human Genome Research Institute.''; and
(B) in paragraph (2)--
(i) by striking subparagraph (D); and
(ii) by redesignating subparagraph (E) as
subparagraph (D).
(2) Subpart 3 of part E of title IV (42 U.S.C. 287c et
seq.) is repealed.
SEC. 203. INCREASED AMOUNT OF GRANT AND OTHER AWARDS.
Section 405(b)(2)(B) (42 U.S.C. 284(b)(2)(B) is amended--
(1) in clause (i), by striking ``$50,000'' and inserting
``$100,000''; and
(2) in clause (ii), by striking ``$50,000'' and inserting
``$100,000''.
SEC. 204. MEETINGS OF ADVISORY COMMITTEES AND COUNCILS.
(a) In General.--Section 406 (42 U.S.C. 284a) is amended--
(1) in subsection (e), by striking ``, but at least three
times each fiscal year''; and
(2) in subsection (h)(2)--
(A) in subparagraph (A)--
(i) in clause (iv), by adding ``and'' after
the semicolon;
(ii) in clause (v), by striking ``; and''
and inserting a period; and
(iii) by striking clause (vi); and
(B) in subparagraph (B), by striking ``, except''
and all that follows through ``year''.
(b) President's Cancer Panel.--Section 415(a)(3) (42 U.S.C. 285a-
4(a)(3)) is amended by striking ``, but not less often than four times
a year''.
(c) Institute of Diabetes and Digestive and Kidney Diseases
Interagency Coordinating Committees.--Section 429(b) (42 U.S.C. 285c-
3(b)) is amended by striking ``, but not less often than four times a
year''.
(d) Institute of Arthritis and Musculoskeletal and Skin Diseases
Interagency Coordinating Committees.--Section 439(b) (42 U.S.C. 285d-
4(b)) is amended by striking ``, but not less often than four times a
year''.
(e) Institute on Deafness and Other Communication Disorders
Interagency Coordinating Committees.--Section 464E(d) (42 U.S.C. 285m-
5(d)) is amended by striking ``, but not less often than four times a
year''.
(f) Institute of Nursing Research Advisory Council.--Section
464X(e) (42 U.S.C. 285q-2(e)) is amended by striking ``, but at least
three times each fiscal year''.
(g) Center for Research Resources Advisory Council.--Section 480(e)
(42 U.S.C. 287a(e)) is amended by striking ``, but at least three times
each fiscal year''.
(h) Application of FACA.--Part B of title IV (42 U.S.C. 284 et
seq.) is amended by adding at the end thereof the following new
section:
``SEC. 409B. APPLICATION OF FEDERAL ADVISORY COMMITTEE ACT.
``Notwithstanding any other provision of law, the provisions of the
Federal Advisory Committee Act (5 U.S.C. App. 2) shall not apply to a
scientific or technical peer review group, established under this
title.''.
SEC. 205. ELIMINATION OR MODIFICATION OF REPORTS.
(a) Public Health Service Act Reports.--The following provisions of
the Public Health Service Act are repealed:
(1) Section 403 (42 U.S.C. 283) relating to the biennial
report of the Director of the National Institutes of Health to
Congress and the President.
(2) Subsection (c) of section 439 (42 U.S.C. 285d-4(c))
relating to the annual report of the Arthritis and
Musculoskeletal Diseases Interagency Coordinating Committee and
the annual report of the Skin Diseases Interagency Coordinating
Committee.
(3) Subsection (j) of section 442 (42 U.S.C. 285d-7(j))
relating to the annual report of the National Arthritis and
Musculoskeletal and Skin Diseases Advisory Board.
(4) Subsection (b) of section 494A (42 U.S.C. 289c-1(b))
relating to the annual report of the Secretary of Health and
Human Services on health services research relating to alcohol
abuse and alcoholism, drug abuse, and mental health.
(5) Subsection (b) of section 503 (42 U.S.C. 290aa-2(b))
relating to the triennial report of the Secretary of Health and
Human Services to Congress.
(b) Report on Disease Prevention.--Section 402(f)(3) (42 U.S.C.
282(f)(3)) is amended by striking ``annually'' and inserting
``biennially''.
(c) Reports of the Coordinating Committees on Digestive Diseases,
Diabetes Mellitus, and Kidney, Urologic and Hematologic Diseases.--
Section 429 (42 U.S.C. 285c-3) is amended by striking subsection (c).
(d) Report of the Task Force on Aging Research.--Section 304 of the
Home Health Care and Alzheimer's Disease Amendments of 1990 (42 U.S.C.
242q-3) is repealed.
(e) Sudden Infant Death Syndrome Research.--Section 1122 (42 U.S.C.
300c-12) is amended--
(1) in subsection (a)--
(A) by striking the subsection designation and
heading; and
(B) by striking ``of the type'' and all that
follows through ``adequate,'' and insert ``, such
amounts each year as will be adequate for research
which relates generally to sudden infant death
syndrome, including high-risk pregnancy and high-risk
infancy research which directly relates to sudden
infant death syndrome, and to the relationship of the
high-risk pregnancy and high-risk infancy research to
sudden infant death syndrome,''; and
(2) by striking subsections (b) and (c).
(f) U.S.-Japan Cooperative Medical Science Program.--Subsection (h)
of section 5 of the International Health Research Act of 1960 is
repealed.
(g) Bioengineering Research.--Not later than 6 months after the
date of enactment of this Act, the Secretary of Health and Human
Services, acting through the Director of the National Institutes of
Health, shall prepare and submit to the Committee on Labor and Human
Resources of the Senate and the Committee on Commerce of the House of
Representatives, a report containing specific plans and timeframes on
how the Director will implement the findings and recommendations of the
report to Congress entitled ``Support for Bioengineering Research''
(submitted in August of 1995 in accordance with section 1912 of the
National Institutes of Health Revitalization Act of 1993 (42 U.S.C. 282
note)).
(h) Conforming Amendments.--Title IV is amended--
(1) in section 404C(c) (42 U.S.C. 283e(c)), by striking
``included'' and all that follows through the period and
inserting ``made available to the committee established under
subsection (e) and included in the official minutes of the
committee'';
(2) in section 404E(d)(3)(B) (42 U.S.C. 283g(d)(3)(B)), by
striking ``for inclusion in the biennial report under section
403'';
(3) in section 406(g) (42 U.S.C. 284a(g))--
(A) by striking ``for inclusion in the biennial
report made under section 407'' and inserting ``as it
may determine appropriate''; and
(B) by striking the second sentence;
(4) in section 407 (42 U.S.C. 284b)--
(A) in the section heading, to read as follows:
``reports'';
and
(B) by striking ``shall prepare for inclusion in
the biennial report made under section 403 a biennial''
and inserting ``may prepare a'';
(5) in section 416(b) (42 U.S.C. 285a-5(b)) by striking
``407'' and inserting ``402(f)(3)'';
(6) in section 417 (42 U.S.C. 285a-6), by striking
subsection (e);
(7) in section 423(b) (42 U.S.C. 285b-6(b)), by striking
``407'' and inserting ``402(f)(3)'';
(8) by striking section 433 (42 U.S.C. 285c-7);
(9) in section 451(b) (42 U.S.C. 285g-3(b)), by striking
``407'' and inserting ``402(f)(3)'';
(10) in section 452(d) (42 U.S.C. 285g-4(d))--
(A) in paragraph (3)--
(i) in subparagraph (A), by striking ``(A)
Not'' and inserting ``Not''; and
(ii) by striking subparagraph (B); and
(B) in the last sentence of paragraph (4), by
striking ``contained'' and all that follows through the
period and inserting ``transmitted to the Director of
NIH.'';
(11) in section 464I(b) (42 U.S.C. 285n-1(b)), by striking
``407'' and inserting ``402(f)(3)'';
(12) in section 464M(b) (42 U.S.C. 285o-1)(b)), by striking
``407'' and inserting ``402(f)(3)'';
(13) in section 464S(b) (42 U.S.C. 285p-1(b)), by striking
``407'' and inserting ``402(f)(3)'';
(14) in section 464X(g) (42 U.S.C. 285q-2(g)) is amended--
(A) by striking ``for inclusion in the biennial
report made under section 464Y'' and inserting ``as it
may determine appropriate''; and
(B) by striking the second sentence;
(15) in section 464Y (42 U.S.C. 285q-3)--
(A) in the section heading, to read as follows:
``reports'';
and
(B) by striking ``shall prepare for inclusion in
the biennial report made under section 403 a biennial''
and inserting ``may prepare a'';
(16) in section 480(g) (42 U.S.C. 287a(g))--
(A) by striking ``for inclusion in the biennial
report made under section 481'' and inserting ``as it
may determine appropriate''; and
(B) by striking the second sentence;
(17) in section 481 (42 U.S.C. 287a-1)--
(A) in the section heading, to read as follows:
``reports'';
and
(B) by striking ``shall prepare for inclusion in
the biennial report made under section 403 a biennial''
and inserting ``may prepare a'';
(18) in section 486(d)(5)(B) (42 U.S.C. 287d(d)(5)(B)), by
striking ``for inclusion in the report required in section
403'';
(19) in section 486B (42 U.S.C. 287d-2) by striking
subsection (b) and inserting the following new subsection:
``(b) Submission.--The Director of the Office shall submit each
report prepared under subsection (a) to the Director of NIH.''; and
(20) in section 492B(f) (42 U.S.C. 289a-2(f)), by striking
``for inclusion'' and all that follows through the period and
inserting ``and the Director of NIH.''.
TITLE III--SPECIFIC INSTITUTES AND CENTERS
Subtitle A--National Cancer Institute
SEC. 301. AUTHORIZATION OF APPROPRIATIONS.
Section 417B (42 U.S.C. 286a-8) is amended--
(1) in subsection (a), by striking ``$2,728,000,000'' and
all that follows through the period and inserting
``$3,000,000,000 for fiscal year 1997.'';
(2) in subsection (b)--
(A) in paragraph (1)--
(i) in the first sentence of subparagraph
(A), by striking ``$225,000,000'' and all that
follows through the first period and inserting
``such sums as may be necessary for fiscal year
1997.''; and
(ii) in the first sentence of subparagraph
(B), by striking ``$100,000,000'' and all that
follows through the first period and inserting
``such sums as may be necessary for fiscal year
1997.''; and
(B) in the first sentence of paragraph (2), by
striking ``$75,000,000'' and all that follows through
the first period and inserting ``such sums as may be
necessary for fiscal year 1997.''; and
(3) in the first sentence of subsection (c), by striking
``$72,000,000'' and all that follows through the first period
and inserting ``such sums as may be necessary for fiscal year
1997.''.
SEC. 302. DES STUDY.
Section 403A(e) (42 U.S.C. 283a(e)) is amended by striking ``1996''
and inserting ``1997''.
Subtitle B--National Heart Lung and Blood Institute
SEC. 311. AUTHORIZATION OF APPROPRIATIONS.
Section 425 (42 U.S.C. 285b-8) is amended by striking
``$1,500,000,000'' and all that follows through the period and
inserting ``$1,600,000,000 for fiscal year 1997.''.
Subtitle C--National Institute of Allergy and Infectious Diseases
SEC. 321. TERRY BEIRN COMMUNITY-BASED AIDS RESEARCH INITIATIVE.
Section 2313(e) (42 U.S.C. 300cc-13(e)) is amended--
(1) in paragraph (1), by striking ``1996'' and inserting
``1997''; and
(2) in paragraph (2), by striking ``1996'' and inserting
``1997''.
Subtitle D--National Institute of Child Health and Human Development
SEC. 331. RESEARCH CENTERS FOR CONTRACEPTION AND INFERTILITY.
Section 452A(g) (42 U.S.C. 285g-5(g)) is amended by striking
``$30,000,000'' and all that follows through the period and inserting
``such sums as may be necessary for fiscal year 1997.''.
Subtitle E--National Institute on Aging
SEC. 341. AUTHORIZATION OF APPROPRIATIONS.
Section 445I (42 U.S.C. 285e-11) is amended by striking
``$500,000,000'' and all that follows through the period and inserting
``$550,000,000 for fiscal year 1997.''.
Subtitle F--National Institute on Alcohol Abuse and Alcoholism
SEC. 351. AUTHORIZATION OF APPROPRIATIONS.
Section 464H(d)(1) (42 U.S.C. 285n(d)(1)) is amended by striking
``300,000,000'' and all that follows through the period and inserting
``$330,000,000 for fiscal year 1997.''.
SEC. 352. NATIONAL ALCOHOL RESEARCH CENTER.
Section 464J(b) (42 U.S.C. 285n-2(b)) is amended--
(1) by striking ``(b) The'' and inserting ``(b)(1) The'';
(2) by striking the third sentence; and
(3) by adding at the end thereof the following new
paragraph:
``(2) As used in paragraph (1), the terms `construction' and `cost
of construction' include--
``(A) the construction of new buildings, the expansion of
existing buildings, and the acquisition, remodeling,
replacement, renovation, major repair (to the extent permitted
by regulations), or alteration of existing buildings, including
architects' fees, but not including the cost of the acquisition
of land or offsite improvements; and
``(B) the initial equipping of new buildings and of the
expanded, remodeled, repaired, renovated, or altered part of
existing buildings; except that
such term shall not include the construction or cost of construction of
so much of any facility as is used or is to be used for sectarian
instruction or as a place for religious worship.''.
Subtitle G--National Institute on Drug Abuse
SEC. 361. AUTHORIZATION OF APPROPRIATIONS.
Section 464L(d)(1) (42 U.S.C. 285o(d)(1)) is amended by striking
``$440,000,000'' and all that follows through the period and inserting
``$500,000,000 for fiscal year 1997.''.
SEC. 362. MEDICATION DEVELOPMENT PROGRAM.
Section 464P(e) (42 U.S.C. 285o-4(e)) is amended by striking
``$85,000,000'' and all that follows through the period and inserting
``such sums as may be necessary for fiscal year 1997''.
SEC. 363. DRUG ABUSE RESEARCH CENTERS.
Section 464N(b) (42 U.S.C. 285o-2(b)) is amended--
(1) by striking ``(b) The'' and inserting ``(b)(1) The'';
(2) by striking the last sentence; and
(3) by adding at the end thereof the following new
paragraph:
``(2) As used in paragraph (1), the terms `construction' and `cost
of construction' include--
``(A) the construction of new buildings, the expansion of
existing buildings, and the acquisition, remodeling,
replacement, renovation, major repair (to the extent permitted
by regulations), or alteration of existing buildings, including
architects' fees, but not including the cost of the acquisition
of land or offsite improvements; and
``(B) the initial equipping of new buildings and of the
expanded, remodeled, repaired, renovated, or altered part of
existing buildings; except that
such term does not include the construction or cost of construction of
so much of any facility as is used or is to be used for sectarian
instruction or as a place for religious worship.''.
Subtitle H--National Institute of Mental Health
SEC. 371. AUTHORIZATION OF APPROPRIATIONS.
Section 464R(f)(1) (42 U.S.C. 285p(f)(1)) is amended by striking
``$675,000,000'' and all that follows through the period and inserting
``$750,000,000 for fiscal year 1997.''.
Subtitle I--National Center for Research Resources
SEC. 381. AUTHORIZATION OF APPROPRIATIONS.
(a) General Authorization.--Section 481A(h) (42 U.S.C. 287a-2(h))
is amended by striking ``$150,000,000'' and all that follows through
the period and inserting ``such sums as may be necessary for fiscal
year 1997.''.
(b) Reservation for Construction of Regional Centers.--Section
481B(a) (42 U.S.C. 287a-3(a)) is amended--
(1) by striking ``shall'' and inserting ``may'';
(2) by striking ``through 1996'' and inserting ``through
1997''; and
(3) by striking ``$5,000,000'' and inserting ``such sums as
may be necessary for each such fiscal year''.
SEC. 382. GENERAL CLINICAL RESEARCH CENTERS.
Part B of title IV (42 U.S.C. 284 et seq.), as amended by section
205(h), is further amended by adding at the end thereof the following
new section:
``SEC. 409C. GENERAL CLINICAL RESEARCH CENTERS.
``(a) Grants.--The Director of the National Center for Research
Resources shall award grants for the establishment of general clinical
research centers to provide the infrastructure for clinical research
including clinical research training and career enhancement. Such
centers shall support clinical studies and career development in all
settings of the hospital or academic medical center involved.
``(b) Activities.--In carrying out subsection (a), the Director of
NIH shall expand the activities of the general clinical research
centers through the increased use of telecommunications and
telemedicine initiatives.
``(c) Authorization of Appropriations.--There are authorized to be
appropriated to make grants under subsection (a), such sums as may be
necessary for each of the fiscal years 1996 and 1997.''.
SEC. 383. ENHANCEMENT AWARDS.
Part B of title IV (42 U.S.C. 284 et seq.), as amended by sections
205(h) and 382, is further amended by adding at the end thereof the
following new section:
``SEC. 409D. ENHANCEMENT AWARDS.
``(a) Clinical Research Career Enhancement Award.--
``(1) In general.--The Director of the National Center for
Research Resources shall make grants (to be referred to as
`clinical research career enhancement awards') to support
individual careers in clinical research.
``(2) Applications.--An application for a grant under this
subsection shall be submitted by an individual scientist at
such time as the Director may require.
``(3) Limitations.--The amount of a grant under this
subsection shall not exceed $130,000 per year per grant. Grants
shall be for terms of 5 years. The Director shall award not
more than 20 grants in the first fiscal year in which grants
are awarded under this subsection. The total number of grants
awarded under this subsection for the first and second fiscal
years in which grants such are awarded shall not exceed 40
grants.
``(4) Authorization of appropriations.--There are
authorized to be appropriated to make grants under paragraph
(1), such sums as may be necessary for fiscal year 1997.
``(b) Innovative Medical Science Award.--
``(1) In general.--The Director of the National Center for
Research Resources shall make grants (to be referred to as
`innovative medical science awards') to support individual
clinical research projects.
``(2) Applications.--An application for a grant under this
subsection shall be submitted by an individual scientist at
such time as the Director requires.
``(3) Limitations.--The amount of a grant under this
subsection shall not exceed $100,000 per year per grant.
``(4) Authorization of appropriations.--There are
authorized to be appropriated to make grants under paragraph
(1), such sums as may be necessary for fiscal year 1997.
``(c) Peer Review.--The Director of NIH, in cooperation with the
Director of the National Center for Research Resources, shall establish
peer review mechanisms to evaluate applications for clinical research
fellowships, clinical research career enhancement awards, and
innovative medical science award programs. Such review mechanisms shall
include individuals who are exceptionally qualified to appraise the
merits of potential clinical research trainees.''.
SEC. 384. WAIVER OF LIMITATIONS.
Section 481A (42 U.S.C. 287a-2) is amended--
(1) in subsection (b)(3)(A), by striking ``9'' and
inserting ``12'';
(2) in subsection (e)--
(A) in paragraph (1)--
(i) in subparagraph (A), by striking ``50''
and inserting ``40''; and
(ii) in subparagraph (B), by striking
``40'' and inserting ``30''; and
(B) in paragraph (4), by striking ``for applicants
meeting the conditions described in paragraphs (1) and
(2) of subsection (c)''; and
(3) in subsection (h), by striking $150,000,000'' and all
that follows through ``1996'' and inserting ``such sums as may
be necessary for fiscal year 1997''.
Subtitle J--National Library of Medicine
SEC. 391. AUTHORIZATION OF APPROPRIATIONS.
Section 468(a) (42 U.S.C. 286a-2(a)) is amended by striking
``$150,000,000'' and all that follows through the period and inserting
``$160,000,000 for fiscal year 1997.''.
SEC. 392. INCREASING THE CAP ON GRANT AMOUNTS.
Section 474(b)(2) (42 U.S.C. 286b-5(b)(2)) is amended by striking
``$1,000,000'' and inserting ``$1,250,000''.
TITLE IV--AWARDS AND TRAINING
SEC. 401. MEDICAL SCIENTIST TRAINING PROGRAM.
(a) Expansion of Program.--Notwithstanding any other provision of
law, the Secretary of Health and Human Services, acting through the
Director of the National Institutes of Health, shall expand the Medical
Scientist Training Program to include fields that will contribute to
training clinical investigators in the skills of performing patient-
oriented clinical research.
(b) Designation of Slots.--In carrying out subsection (a), the
Director of the National Institutes of Health shall designate a
specific percentage of positions under the Medical Scientist Training
Program for use with respect to the pursuit of a Ph.D. degree in the
disciplines of economics, epidemiology, public health, bioengineering,
biostatistics and bioethics, and other fields determined appropriate by
the Director.
SEC. 402. RAISE IN MAXIMUM LEVEL OF LOAN REPAYMENTS.
(a) Repayment Programs With Respect to AIDS.--Section 487A (42
U.S.C. 288-1) is amended--
(1) in subsection (a), by striking ``$20,000'' and
inserting ``$35,000''; and
(2) in subsection (c), by striking ``1996'' and inserting
``1997''.
(b) Repayment Programs With Respect to Contraception and
Infertility.--Section 487B(a) (42 U.S.C. 288-2(a)) is amended by
striking ``$20,000'' and inserting ``$35,000''.
(c) Repayment Programs With Respect to Research Generally.--Section
487C(a)(1) (42 U.S.C. 288-3(a)(1)) is amended by striking ``$20,000''
and inserting ``$35,000''.
(d) Repayment Programs With Respect to Clinical Researchers From
Disadvantaged Backgrounds.--Section 487E(a) (42 U.S.C. 288-5(a)) is
amended--
(1) in paragraph (1), by striking ``$20,000'' and inserting
``$35,000''; and
(2) in paragraph (3), by striking ``338C'' and inserting
``338B, 338C''.
SEC. 403. GENERAL LOAN REPAYMENT PROGRAM.
Part G of title IV (42 U.S.C. 288 et seq.) is amended by inserting
after section 487E, the following new section:
``SEC. 487F. GENERAL LOAN REPAYMENT PROGRAM.
``(a) Establishment.--
``(1) In general.--The Secretary, acting through the
Director of NIH, shall carry out a program of entering into
agreements with appropriately qualified health professionals
under which such health professionals agree to conduct research
with respect to the areas identified under paragraph (2) in
consideration of the Federal Government agreeing to repay, for
each year of such service, not more than $35,000 of the
principal and interest of the educational loans of such health
professionals.
``(2) Research areas.--In carrying out the program under
paragraph (1), the Director of NIH shall annually identify
areas of research for which loan repayments made be awarded
under paragraph (1).
``(3) Term of agreement.--A loan repayment agreement under
paragraph (1) shall be for a minimum of two years.
``(b) Applicability of Certain Provisions.--With respect to the
National Health Service Corps Loan Repayment Program established in
subpart III of part D of title III, the provisions of such subpart
shall, except as inconsistent with subsection (a) of this section,
apply to the program established in such subsection (a) in the same
manner and to the same extent as such provisions apply to the National
Health Service Corps Loan Repayment Program established in such
subpart.
``(c) Authorization of Appropriations.--For the purpose of carrying
out this section, there are authorized to be appropriated such sums as
may be necessary for fiscal year 1997.''.
SEC. 404. CLINICAL RESEARCH ASSISTANCE.
(a) National Research Service Awards.--Section 487(a)(1)(C) (42
U.S.C. 288(a)(1)(C)) is amended--
(1) by striking ``50 such'' and inserting ``100 such''; and
(2) by striking ``1996'' and inserting ``1997''.
(b) Loan Repayment Program.--Section 487E (42 U.S.C. 288-5) is
amended--
(1) in the section heading, by striking ``from
disadvantaged backgrounds'';
(2) in subsection (a)(1), by striking ``who are from
disadvantaged backgrounds'';
(3) in subsection (b)--
(A) by striking ``Amounts'' and inserting the
following:
``(1) In general.--Amounts''; and
(B) by adding at the end thereof the following new
paragraph:
``(2) Disadvantaged backgrounds set-aside.--In carrying out
this section, the Secretary shall ensure that not less than 50
percent of the amounts appropriated for a fiscal year are used
for contracts involving those appropriately qualified health
professionals who are from disadvantaged backgrounds.''; and
(4) by adding at the end thereof the following new
subsections:
``(c) Clinical Research Training Position.--A position shall be
considered a clinical research training position under subsection
(a)(1) if such position involves an individual serving in a general
clinical research center or other organizations and institutions
determined to be appropriate by the Director of NIH, or a physician
receiving a clinical research career enhancement award or NIH
intramural research fellowship.
``(d) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section such sums as may be necessary
for each fiscal year.''.
TITLE V--RESEARCH WITH RESPECT TO AIDS
SEC. 501. COMPREHENSIVE PLAN FOR EXPENDITURE OF AIDS APPROPRIATIONS.
Section 2353(d)(1) (42 U.S.C. 300cc-40b(d)(1)) is amended by
striking ``through 1996'' and inserting ``through 1997''.
SEC. 502. EMERGENCY AIDS DISCRETIONARY FUND.
Section 2356(g)(1) (42 U.S.C. 300cc-43(g)(1)) is amended by
striking ``$100,000,000'' and all that follows through the period and
inserting ``such sums as may be necessary for fiscal year 1997''.
TITLE VI--GENERAL PROVISIONS
Subtitle A--Authority of the Director of NIH
SEC. 601. AUTHORITY OF THE DIRECTOR OF NIH.
Section 402(b) (42 U.S.C. 282(b)) is amended--
(1) in paragraph (11), by striking ``and'' at the end
thereof;
(2) in paragraph (12), by striking the period and inserting
a semicolon; and
(3) by adding after paragraph (12), the following new
paragraphs:
``(13) may conduct and support research training--
``(A) for which fellowship support is not provided
under section 487; and
``(B) which does not consist of residency training
of physicians or other health professionals; and
``(14) may appoint physicians, dentists, and other health
care professionals, subject to the provisions of title 5,
United States Code, relating to appointments and
classifications in the competitive service, and may compensate
such professionals subject to the provisions of chapter 74 of
title 38, United States Code.''.
Subtitle B--Office of Rare Disease Research
SEC. 611. ESTABLISHMENT OF OFFICE FOR RARE DISEASE RESEARCH.
Part A of title IV of the Public Health Service Act (42 U.S.C. 281
et seq.) is amended by adding at the end thereof the following new
section:
``SEC. 404F. OFFICE FOR RARE DISEASE RESEARCH.
``(a) Establishment.--There is established within the Office of the
Director of the National Institutes of Health an office to be known as
the Office for Rare Disease Research (in this section referred to as
the `Office'). The Office shall be headed by a director, who shall be
appointed by the Director of the National Institutes of Health.
``(b) Purpose.--The purpose of the Office is to promote and
coordinate the conduct of research on rare diseases through a strategic
research plan and to establish and manage a rare disease research
clinical database.
``(c) Advisory Council.--The Secretary shall establish an advisory
council for the purpose of providing advice to the director of the
Office concerning carrying out the strategic research plan and other
duties under this section. Section 222 shall apply to such council to
the same extent and in the same manner as such section applies to
committees or councils established under such section.
``(d) Duties.--In carrying out subsection (b), the director of the
Office shall--
``(1) develop a comprehensive plan for the conduct and
support of research on rare diseases;
``(2) coordinate and disseminate information among the
institutes and the public on rare diseases;
``(3) support research training and encourage the
participation of a diversity of individuals in the conduct of
rare disease research;
``(4) identify projects or research on rare diseases that
should be conducted or supported by the National Institutes of
Health;
``(5) develop and maintain a central database on current
government sponsored clinical research projects for rare
diseases;
``(6) determine the need for registries of research
subjects and epidemiological studies of rare disease
populations; and
``(7) prepare biennial reports on the activities carried
out or to be carried out by the Office and submit such reports
to the Secretary and the Congress.''.
Subtitle C--Certain Reauthorizations
SEC. 621. NATIONAL RESEARCH SERVICE AWARDS.
Section 487(d) (42 U.S.C. 288(d)) is amended by striking
``$400,000,000'' and all that follows through the first period and
inserting ``such sums as may be necessary for fiscal year 1997.''.
SEC. 622. NATIONAL FOUNDATION FOR BIOMEDICAL RESEARCH.
Section 499(m)(1) (42 U.S.C. 290b(m)(1)) is amended by striking
``an aggregate'' and all that follows through the period and inserting
``such sums as may be necessary for fiscal year 1997.''.
Subtitle D--Miscellaneous Provisions
SEC. 631. ESTABLISHMENT OF NATIONAL FUND FOR HEALTH RESEARCH.
Part A of title IV (42 U.S.C. 281 et seq.), as amended by section
611, is further amended by adding at the end thereof the following new
section:
``SEC. 404G. ESTABLISHMENT OF NATIONAL FUND FOR HEALTH RESEARCH.
``(a) Establishment.--There is established in the Treasury of the
United States a fund, to be known as the `National Fund for Health
Research' (hereafter in this section referred to as the `Fund'),
consisting of such amounts as are transferred to the Fund and any
interest earned on investment of amounts in the Fund.
``(b) Obligations From Fund.--
``(1) In general.--Subject to the provisions of paragraph
(2), with respect to the amounts made available in the Fund in
a fiscal year, the Secretary shall distribute all of such
amounts during any fiscal year to research institutes and
centers of the National Institutes of Health in the same
proportion to the total amount received under this section, as
the amount of annual appropriations under appropriations Acts
for each member institute and centers for the fiscal year bears
to the total amount of appropriations under appropriations Acts
for all research institutes and centers of the National
Institutes of Health for the fiscal year.
``(2) Trigger and release of monies.--No expenditure shall
be made under paragraph (1) during any fiscal year in which the
annual amount appropriated for the National Institutes of
Health is less than the amount so appropriated for the prior
fiscal year.''.
SEC. 632. DEFINITION OF CLINICAL RESEARCH.
Part A of title IV (42 U.S.C. 281 et seq.) as amended by sections
611 and 631, is further amended by adding at the end thereof the
following new section:
``SEC. 404H. DEFINITION OF CLINICAL RESEARCH.
``As used in this title, the term `clinical research' means patient
oriented clinical research conducted with human subjects, or research
on the causes and consequences of disease in human populations, or on
material of human origin (such as tissue specimens and cognitive
phenomena) for which an investigator or colleague directly interacts
with human subjects in an outpatient or inpatient setting to clarify a
problem in human physiology, pathophysiology, or disease, epidemiologic
or behavioral studies, outcomes research, or health services
research.''.
SEC. 633. ESTABLISHMENT OF A PEDIATRIC RESEARCH INITIATIVE.
Part A of title IV (42 U.S.C. 281 et seq.), as amended by sections
611, 631, and 632, is further amended by adding at the end the
following new section:
``SEC. 404I. PEDIATRIC RESEARCH INITIATIVE
``(a) Establishment.--The Secretary shall establish within the
Office of the Director of NIH a Pediatric Research Initiative
(hereafter in this section referred to as the `Initiative'). The
Initiative shall be headed by the Director of NIH.
``(b) Purpose.--The purpose of the Initiative is to provide funds
to enable the Director of NIH to encourage--
``(1) increased support for pediatric biomedical research
within the National Institutes of Health to ensure that the
expanding opportunities for advancement in scientific
investigations and care for children are realized;
``(2) enhanced collaborative efforts among the Institutes
to support multidisciplinary research in the areas that the
Director deems most promising;
``(3) increased support for pediatric outcomes and medical
effectiveness research to demonstrate how to improve the
quality of children's health care while reducing cost;
``(4) the development of adequate pediatric clinical trials
and pediatric use information to promote the safer and more
effective use of prescription drugs in the pediatric
population; and
``(5) recognition of the special attention pediatric
research deserves.
``(c) Duties.--In carrying out subsection (b), the Director of NIH
shall--
``(1) consult with the Institutes and other advisors as the
Director determines appropriate when considering the role of
the Institute for Child Health and Human Development;
``(2) have broad discretion in the allocation of any
Initiative assistance among the Institutes, among types of
grants, and between basic and clinical research so long as
the--
``(A) assistance is directly related to the
illnesses and diseases of children; and
``(B) assistance is extramural in nature; and
``(3) be responsible for the oversight of any newly
appropriated Initiative funds and be accountable with respect
to such funds to Congress and to the public.
``(d) Authorization.--There is authorized to be appropriated to
carry out this section, $50,000,000 for fiscal years 1997 through 1999.
``(e) Transfer of Funds.--The Director of NIH may transfer amounts
appropriated to any of the Institutes for a fiscal year to the
Initiative to carry out this section.''.
SEC. 634. DIABETES RESEARCH.
(a) Findings.--The Congress finds as follows:
(1) Diabetes is a serious health problem in America.
(2) More than 16,000,000 Americans suffer from diabetes.
(3) Diabetes is the fourth leading cause of death in
America, taking the lives of more than 169,000 people annually.
(4) Diabetes disproportionately affects minority
populations, especially African-Americans, Hispanics, and
Native Americans.
(5) Diabetes is the leading cause of new blindness in
adults over age 30.
(6) Diabetes is the leading cause of kidney failure
requiring dialysis or transplantation, affecting more than
56,000 Americans each year.
(7) Diabetes is the leading cause of nontraumatic
amputations, affecting 54,000 Americans each year.
(8) The cost of treating diabetes and its complications are
staggering for our Nation.
(9) Diabetes accounted for health expenditures of
$105,000,000,000 in 1992.
(10) Diabetes accounts for over 14 percent of our Nation's
health care costs.
(11) Federal funds invested in diabetes research over the
last two decades has led to significant advances and, according
to leading scientists and endocrinologists, has brought the
United States to the threshold of revolutionary discoveries
which hold the potential to dramatically reduce the economic
and social burden of this disease.
(12) The National Institute of Diabetes and Digestive and
Kidney Diseases supports, in addition to many other areas of
research, genetic research, islet cell transplantation
research, and prevention and treatment clinical trials focusing
on diabetes. Other research institutes within the National
Institutes of Health conduct diabetes-related research focusing
on its numerous complications, such as heart disease, eye and
kidney problems, amputations, and diabetic neuropathy.
(b) Increased Funding Regarding Diabetes.--With respect to the
conduct and support of diabetes-related research by the National
Institutes of Health, there are authorized to be appropriated for such
purpose--
(1) for each of the fiscal years 1997 through 1999, an
amount equal to the amount appropriated for such purpose for
fiscal year 1996; and
(2) for the 3-fiscal year period beginning with fiscal year
1997, an additional amount equal to 25 percent of the amount
appropriated for such purpose for fiscal year 1996.
SEC. 635. PARKINSON'S RESEARCH.
Part B of title IV (42 U.S.C. 284 et seq.), as amended by sections
204, 382 and 383, is further amended by adding at the end the following
section:
``parkinson's disease
``Sec. 409E. (a) In General.--The Director of NIH shall establish a
program for the conduct and support of research and training with
respect to Parkinson's disease.
``(b) Inter-institute Coordination.--
``(1) In general.--The Director of NIH shall provide for
the coordination of the program established under subsection
(a) among all of the national research institutes conducting
Parkinson's research.
``(2) Conference.--Coordination under paragraph (1) shall
include the convening of a research planning conference not
less frequently than once every 2 years. Each such conference
shall prepare and submit to the Committee on Appropriations and
the Committee on Labor and Human Resources of the Senate and
the Committee on Appropriations and the Committee on Commerce
of the House of Representatives a report concerning the
conference.
``(c) Morris K. Udall Research Centers.--
``(1) In general.--The Director of NIH shall award Core
Center Grants to encourage the development of innovative
multidisciplinary research and provide training concerning
Parkinson's. The Director shall award not more than 10 Core
Center Grants and designate each center funded under such
grants as a Morris K. Udall Center for Research on Parkinson's
Disease.
``(2) Requirements.--
``(A) In general.--With respect to Parkinson's,
each center assisted under this subsection shall--
``(i) use the facilities of a single
institution or a consortium of cooperating
institutions, and meet such qualifications as
may be prescribed by the Director of the NIH;
and
``(ii) conduct basic and clinical research.
``(B) Discretionary requirements.--With respect to
Parkinson's, each center assisted under this subsection
may--
``(i) conduct training programs for
scientists and health professionals;
``(ii) conduct programs to provide
information and continuing education to health
professionals;
``(iii) conduct programs for the
dissemination of information to the public;
``(iv) separately or in collaboration with
other centers, establish a nationwide data
system derived from patient populations with
Parkinson's, and where possible, comparing
relevant data involving general populations;
``(v) separately or in collaboration with
other centers, establish a Parkinson's Disease
Information Clearinghouse to facilitate and
enhance knowledge and understanding of
Parkinson's disease; and
``(vi) separately or in collaboration with
other centers, establish a national education
program that fosters a national focus on
Parkinson's and the care of those with
Parkinson's.
``(3) Stipends regarding training programs.--A center may
use funds provided under paragraph (1) to provide stipends for
scientists and health professionals enrolled in training
programs under paragraph (2)(B).
``(4) Duration of support.--Support of a center under this
subsection may be for a period not exceeding five years. Such
period may be extended by the Director of NIH for one or more
additional periods of not more than five years if the
operations of such center have been reviewed by an appropriate
technical and scientific peer review group established by the
Director and if such group has recommended to the Director that
such period should be extended.
``(d) Morris K. Udall Awards for Innovation in Parkinson's Disease
Research.--The Director of NIH shall establish a grant program to
support innovative proposals leading to significant breakthroughs in
Parkinson's research. Grants under this subsection shall be available
to support outstanding neuroscientists and clinicians who bring
innovative ideas to bear on the understanding of the pathogenesis,
diagnosis and treatment of Parkinson's disease.
``(e) Authorization of Appropriations.--For the purpose of carrying
out this section, there are authorized to be appropriated $80,000,000
for fiscal year 1997.''.
SEC. 636. PAIN RESEARCH CONSORTIUM.
(a) Short Title.--This section may be cited as the ``Pain Research
Consortium Act of 1996''.
(b) Operation.--Part E of title IV (42 U.S.C. 287 et seq.) is
amended by adding at the end thereof the following new subpart:
``Subpart 5--Pain Research Consortium
``SEC. 485E. ESTABLISHMENT AND PURPOSE OF THE CONSORTIUM.
``(a) Establishment.--The Director of NIH shall, subject to the
availability of appropriations, and acting in cooperation with
appropriate Institutes and with leading experts in pain research and
treatment, establish within the National Institutes of Health, a Pain
Research Consortium (hereafter referred to in this subpart as the
`Consortium').
``(b) Purpose.--It is the purpose of the Pain Research Consortium
to--
``(1) provide a structure for coordinating pain research
activities;
``(2) facilitate communications among Federal and State
governmental agencies and private sector organization
(including extramural grantees) concerned with pain;
``(3) share information concerning research and related
activities being conducted in the area of pain;
``(4) encourage the recruitment and retention of
individuals desiring to conduct pain research;
``(5) develop collaborative pain research efforts;
``(6) avoid unnecessary duplication of pain research
efforts; and
``(7) achieve a more efficient use of Federal and private
sector research funds.
``(c) Composition.--The Consortium shall be composed of
representatives of--
``(1) the National Institute of Neurological Disorders and
Stroke;
``(2) the National Institute of Drug Abuse;
``(3) the National Institute of General Medical Sciences;
``(4) the National Institute of Dental Research;
``(5) the National Health, Lung, and Blood Institute;
``(6) the National Cancer Institute;
``(7) the National Institute of Mental Health;
``(8) the National Institute of Nursing Research;
``(9) the National Center for Research Resources;
``(10) the National Institute of Child Health and Human
Development;
``(11) the National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
``(12) the National Institute on Aging;
``(13) pain management practitioners, which may include
physicians, psychologists, physical medicine and rehabilitation
service representatives (including physical therapists and
occupational therapists), nurses, dentists, and chiropractors;
and
``(14) patient advocacy groups.
``(d) Activities.--The Consortium shall coordinate and support
research, training, health information dissemination and related
activities with respect to--
``(1) acute pain;
``(2) cancer and HIV-related pain;
``(3) back pain, headache pain, and facial pain; and
``(4) other painful conditions.
``(e) Authorization of Appropriations.--There is authorized to be
appropriated to carry out this section, $5,000,000 for fiscal year
1997.''.
Subtitle E--Repeals and Conforming Amendments
SEC. 641. REPEALS AND CONFORMING AMENDMENTS.
(a) Renaming of Division of Research Resources.--Section 403(5) (42
U.S.C. 283(5)) is amended by striking ``Division of Research
Resources'' and inserting ``National Center for Research Resources''.
(b) Renaming of National Center for Nursing Research.--
(1) Section 403(5) (42 U.S.C. 283(5)) is amended by
striking ``National Center for Nursing Research'' and inserting
``National Institute of Nursing Research''.
(2) Section 408(a)(2) (42 U.S.C. 284c(a)(2)) is amended by
striking ``National Center for Nursing Research'' and inserting
``National Institute of Nursing Research''.
(c) Renaming of Chief Medical Director for Veterans Affairs.--
(1) Section 406 (42 U.S.C. 284a) is amended--
(A) in subsection (b)(2)(A), by striking ``Chief
Medical Director of the Department of Veterans Affairs
or the Chief Dental Director of the Department of
Veterans Affairs'' and inserting ``Under Secretary for
Health of the Department of Veterans Affairs''; and
(B) in subsection (h)(2)(A)(v) by striking ``Chief
Medical Director of the Department of Veterans
Affairs,'' and inserting ``Under Secretary for Health
of the Department of Veterans Affairs''.
(2) Section 424(c)(3)(B)(x) (42 U.S.C. 285b-7(c)(3)(B)(x))
is amended by striking ``Chief Medical Director of the
Veterans' Administration'' and inserting ``Under Secretary for
Health of the Department of Veterans Affairs''.
(3) Section 429(b) (42 U.S.C. 285c-3(b)) is amended by
striking ``Chief Medical Director of the Veterans'
Administration'' and inserting ``Under Secretary for Health of
the Department of Veterans Affairs''.
(4) Section 430(b)(2)(A)(i) (42 U.S.C. 285c-4(b)(2)(A)(i))
is amended by striking ``Chief Medical Director of the
Department of Veterans Affairs'' and inserting ``Under
Secretary for Health of the Department of Veterans Affairs''.
(5) Section 439(b) (42 U.S.C. 285d-4(b)) is amended by
striking ``Chief Medical Director of the Department of Veterans
Affairs'' and inserting ``Under Secretary for Health of the
Department of Veterans Affairs''.
(6) Section 452(f)(3)(B)(xi) (42 U.S.C. 285g-
4(f)(3)(B)(xi)) is amended by striking ``Chief Medical Director
of the Department of Veterans Affairs'' and inserting ``Under
Secretary for Health of the Department of Veterans Affairs''.
(7) Section 466(a)(1)(B) (42 U.S.C. 286a(a)(1)(B)) is
amended by striking ``Chief Medical Director of the Department
of Veterans Affairs'' and inserting ``Under Secretary for
Health of the Department of Veterans Affairs''.
(8) Section 480(b)(2)(A) (42 U.S.C. 287a(b)(2)(A)) is
amended by striking ``Chief Medical Director of the Department
of Veterans Affairs'' and inserting ``Under Secretary for
Health of the Department of Veterans Affairs''.
(b) Advisory Councils.--Section 406(h) (42 U.S.C. 284a(h)) is
amended--
(1) by striking paragraph (1); and
(2) in paragraph (2)--
(A) by striking ``(2)(A) The'' and inserting ``(1)
The'';
(B) by redesignating subparagraph (B) as paragraph
(2); and
(C) by redesignating clauses (i) through (vi) of
paragraph (1) (as so redesignated) as subparagraphs (A)
through (F), respectively.
(c) Diabetes and Digestive and Kidney Disorders Advisory Boards.--
Section 430 (42 U.S.C. 285c-4) is repealed.
(d) National Arthritis and Musculoskeletal and Skin Diseases
Advisory Board.--Section 442 (42 U.S.C. 285d-7) is repealed.
(e) Research Centers Regarding Chronic Fatigue Syndrome.--Subpart 6
of part C of title IV (42 U.S.C. 285f et seq.) is amended by
redesignating the second section 447 (42 U.S.C. 285f-1) as section
447A.
(f) National Institute on Deafness Advisory Board.--Section 464D
(42 U.S.C. 285m-4) is repealed.
(g) Biomedical and Behavioral Research Personnel Study.--Section
489 (42 U.S.C. 288b) is amended--
(1) by striking subsection (b); and
(2) by redesignating subsection (c) as subsection (b).
(h) National Commission on Alcoholism and Other Alcohol-Related
Problems.--Section 18 of the Comprehensive Alcohol Abuse and Alcoholism
Prevention, Treatment, and Rehabilitation Act Amendments of 1979 (42
U.S.C. 4541 note) is repealed.
(i) Advisory Council on Hazardous Substances Research and
Training.--Section 311(a) of the Comprehensive Environmental Response,
Compensation and Liability Act of 1980 (42 U.S.C. 9660(a)) is amended--
(1) by striking paragraph (5); and
(2) in the last sentence of paragraph (6), by striking
``the relevant Federal agencies referred to in subparagraph (A)
of paragraph (5)'' and inserting ``relevant Federal agencies''.
Passed the Senate September 26, 1996.
Attest:
GARY SISCO,
Secretary.